Firm’s pump design gets boost from new study
- Credit: Archant
A pump which could help breast cancer sufferers has been given the thumbs up by an academic study.
A group of academics led by Professor Steven Ley at Cambridge university’s chemistry department carried out research which indicates the innovative new V-3 pump system, designed by Bury St Edmunds-based Vapourtec, could help people living with or at risk of cancer.
It was used in a process that enables efficient and controlled production of breast cancer drug Tamoxifen using a flow chemistry process.
The firm’s founder and boss Duncan Guthrie said: “This could be one of our biggest breakthroughs to date.”
“Existing approaches for the production of Tamoxifen present a number of challenges. However, the V-3 provides an alternative, novel approach resulting from its ability to pump previously difficult to handle reagents based on its unique pumping ability,” he said.
You may also want to watch:
Research team member Dr Duncan Browne said the pump had enabled it to expand previous flow chemical reactions into continuous processes that produce significant quantities of materials. Vapourtec applications specialist Andrew Mansfield described the paper as “very important”.
- 1 Body found in the River Orwell
- 2 Police confirm body found in River Orwell was of a 17-year-old boy
- 3 HOW THE NIGHT UNFOLDED: Witches prove too hot for Lynn
- 4 Could any released Bristol City players reunite with Ashton at Ipswich?
- 5 Woman who posed as food bank staff steals Easter eggs from Morrisons
- 6 Ipswich Town transfer rumour: Blues 'eye' Sheffield Wednesday midfielder
- 7 What has changed in Woodbridge over lockdown?
- 8 Exit Interview: Nydam showed 'heart, desire and hunger' but was never able to take the next step
- 9 Reduce your dementia risk with 7 lifestyle changes
- 10 Tributes to 'loyal, caring' man, 28, who died after A14 crash